Female Pathology

HPV

Location Neoplasia
Vulvar VIN, vulvular intraepithelial neoplasia
Vagina VAIN, vaginal intraepithelial neoplasia
Cervix CIN, cervical intraepithelial neoplasia

Vaccine

Fence circles 6, 11, 16, 18 only

Pap Smear

Pap Smear: gold standard screening test used for the detection of squamous dysplasia and cancer. It can also be used as a tool to evaluate hormone status.

Screening begins at age 21 and is initially performed every 3 years.

In order to be considered an adequate sample, it must contain sampling from the squamocolumnar junction (transformation zone) cells. This would include both metaplastic squamous cells and mucus-secreting columnar cells.

Abnormal Pap smear findings include dysplasia or carcinoma in situ (CIS), both of which are characterized by the following findings on histology:

Pap smears. A‚ Normal. Large‚ flat cells with small nuclei. B‚ Dysplasia. Large‚ dark nuclei indicate damaged DNA; cytoplasmic halo indicates human papillomavirus (HPV) effect. C‚ Malignant. Compact cells with huge‚ irregular‚ dark nuclei indicate malignancy.

Normal (left) and abnormal pap smear. Normal: small nucleus to cytoplasm ratio, pink color.

Abnormal pap smear is followed with colposcopy and biopsy. Colposcopy:

Pap smear has limited efficacy in screening for adenocarcinoma (does not have stages)

Vulvar SCC

Relatively rare, malignant carcinoma arising from the squamous epithelium of the vulva.

The lesions commonly present as leukoplakia

Biopsy may be required to distinguish vulvar carcinoma from other causes of leukoplakia (lichen problems).

The etiology may be HPV-related (associated with “high-risk” types 16 and 18) or non-HPV related.

HPV 16 and 18 makes E6 and E7 that increases destruction of p53 and Rb. Loss of these tumor suppressor proteins increase risk for VAIN, CIN , VIN

HPV related vulvar carcinoma (VIN, Vulvar Intraepithelial Neoplasia) risk factors related to HPV exposure, multiple partners, early intercourse. Women of reproductive age, 40-50s (get around 25-30, takes 15 years to develop)

Non-HPV vulvar carcinoma

Often arise from long-standing lichen sclerosis, which are generally seen in elderly women (average age is >70 years old).

Vaginal SCC

Carcinoma arising from the squamous epithelium lining the vaginal mucosa.

The route of lymph node metastasis differs based on the location of the primary tumor:

The distinct routes of lymphatic drainage correspond to the embryologic origin of different parts of the the vagina; recall that the upper ⅓ of the vagina is derived from the paramesonephric duct, while the lower ⅔ of the vagina is derived from the urogenital sinus.

CIN and Cervical Carcinoma

CIN

Pathogenesis:

**Koilocytes **(seen in all HPV related diseases) are seen beginning at the basal layer and extending outward. These are cells with a clear halo surrounding hyperchromatic, atypical nuclei. Increased mitotic activity.

Classification of CIN:

High grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer (squamous cell carcinoma) of the cervix: CIN III Development of dysplasia and carcinoma of the cervix. Repeated human papillomavirus (HPV) infections convert normal epithelium (left) into increasingly severe dysplasia until malignant epithelium breaks through the basement membrane to become invasive cancer‚ capable of metastasis by invasion of blood vessels and lymphatics.

CIN I to III can regress. CIS cannot regress and will proceed to invasive squamous cell carcinoma once it breaks through basement membrane.

Carcinoma in situ is characterized by atypical changes extending through the entire thickness of the epithelium.

Invasive cervical carcinoma

Two subtypes of cervical carcinoma are SCC (80%) and adenocarcinoma (columnar cells). Both types are related to HPV.

(Cervical carcinoma risk factors)Risk factors for cervical carcinoma are:

Cervical carcinoma is AIDS defining illness

Cervical cancer is now the least common gynecologic cancer due to the success of the Pap smear screening tests. It typically presents with foul smelling discharge and irregular bleeding, which is often postcoital.

Advanced tumors invade locally through anterior uterine wall into the bladder, blocking the ureters. Hydronephrosis with postrenal failure is a common cause of death in advanced cervical carcinoma.

Cervical squamous cell carcinoma

Pap smear is the screening test of choice because it can discover cervical dysplasia before it progresses to invasive carcinoma. Dysplastic cells demonstrate koilocytosis (cellular changes in which cells appear to have halo nuclei on cytologic examination).

Vulva Pathology

Anatomy

Bartholin Cysts

Cystic dilation of Bartholin glands, happens in women of reproductive age due to infection and STI

Bartholin gland produce mucus-like fluid via ducts into lower vestibule.

Bartholin cysts typically arise due to inflammation and obstruction of the gland

Bartholin cysts commonly present with a **unilateral, painful cystic lesion at the lower vestibule adjacent to the vaginal canal. **

Lichen Simplex Chronicus

Lichen Simplex Chronicus is a benign lesion characterized by hyperplasia of the vulvar squamous epithelium.

The lesions of lichen simplex chronicus commonly present as leukoplakia with thick, leathery vulvar skin

The development of lichen simplex chronicus is associated with chronic irritation and scratching of the vulva.

Lichen Simplex Chronicus **does not carry an increased risk **of squamous cell carcinoma.

Condyloma

Condyloma is a sexually transmitted lesion that can be caused by either HPV 6, 11 (condyloma accuminatum) or secondary syphilis (condyloma latum). These lesions can be differentiated by the following:

condyloma accuminatum:

Condylomas rarely progress to carcinoma, and this is because HPV types 6 and 11 are considered “low-risk.”

Histologically, condylomas associated with HPV are characterized by koilocytes with “raisin-like” nuclei surrounded by a halo.

Low mag: warts like High mag: koilocytes, raisin like nucleus

Extramammary Paget Disease

Extramammary Paget Disease is characterized by malignant epithelial cells with pale cytoplasm and eccentric, hyperchromatic nuclei (Paget cells) in the epidermis of the vulva.

Extramammary disease, malignant paget cells infiltrating dermis. Epithelial near top. Looks like melanoma.

The lesions of extramammary paget disease commonly present as erythematous, pruritic, ulcerated vulvar skin

Extramammary Paget disease represents carcinoma in situ (CIS), however, unlike paget disease of the nipple (breast involvement), there is usually no underlying carcinoma.

It is very important to distinguish extramammary paget disease from melanoma, which is a lesion that rarely occurs on the vulva. The following histologic staining is used to make the differentiation:

Paget cells: PAS positive, keratin positive, S100 negative (Pas: mucous secretion from epithelial cells)

Melanoma: PAS negative, keratin negative, S100 positive

Vagina Pathology

Anatomy

Adenosis

Focal persistence of columnar epithelium in the upper vagina.

During development, squamous epithelium from lower 1/3 (urogenital sinus) of the vagina grows upward to replace columnar epithelium lining of upper 2/3 of vagina (mullerian ducts)

In utero exposure to diethylstilbestrol (DES) is a major risk factor for adenosis of the vagina.

Adenosis of vagina:

Clear Cell Adenocarcinoma

Clear Cell Adenocarcinoma of the vagina is a rare, malignant tumor of glands with clear cytoplasm that is a complication associated with diethylstilbestrol-associated vaginal adenosis. It is commonly associated with exposure to DES in utero (Estrogen crosses placenta, distrupting development of squamous epithelium)

When viewed microscopically, the tissue demonstrates cells with hyperchromatic nuclei (also known as "Hobnail" nuclei) protruding into the gland lumen.

Clear cell adnocarcinoma: Hobnail nuclei:

Sarcoma Botryoides

malignant mesenchymal proliferation of immature skeletal muscle. This is a rare variant of rhabdomyosarcoma.

Aka Embryonal Rhabdomyosarcoma

Most commonly seen in girls and boys younger than age 4.

Grossly, it presents as multiple polypoid masses resembling a "bunch of grapes" projecting out of the vagina, and will often be seen protruding from the vulva; clear/yellow in color. In young boys it will be seen protruding from the penis.

Embryonal rhabdomyosarcoma (sarcoma botryoides) of vagina. The grape-like tumor protrudes through the introitus:

Microscopic observation of Sarcoma Botryoides reveals **striated, spindle shaped tumor cells known as rhabdomyoblasts **(immature muscle cells). Has cytoplasmic cross-striations like skeletal muscle cells

Stains positive for desmin (intermediate filaments in muscle cells) and myogenin (transcription factor only found in immature muscle cells).

Cervix Pathology

Anatomy

Cervicitis

is condition that involves inflammation of the cervix that typically occurs in the transformation zone. Most commonly (>50%) caused by ascending infections from **Chlamydia **or Gonorrhea

Other common causes cervicitis include:

Acute cervicitis

Follicular cervicitis

Uterine Pathology

Anatomy

Endometritis

Endometritis is infection of the endometrium. It is the most common genital tract infection following delivery or abortion, especially in preterm deliveries. It is most often caused by bacterial infection of the endometrium.

Acute (early-onset) Endometritis is caused by a bacterial infection (e.g. GBS (Group B Strep), Bacteroides, Peptostreptococcus, Ureaplasma) of the endometrium.  Usually due to retained products of conception (after delivery or miscarriage) that act as a nidus for infection.

Presents as fever, abnormal uterine bleeding, and pelvic pain.

Biopsy of the endometrium will reveal neutrophils within the endometrial glands.

Acute endometritis

Chronic (late-onset) Endometritis is caused by chronic inflammation of the endometrium.  Causes include retained products of conception, chronic pelvic inflammatory disease (e.g. Chlamydia), IUD (e.g. Actinomyces israelii), and TB.

Biopsy of the endometrium will reveal lymphocytes and plasma cells seen within endometrial stroma. Also, granulomas will be seen in the case of TB infection. Plasma cells are necessary for the diagnosis of chronic endometritis given that lymphocytes are normally found in the endometrium.  Chronic endometritis

Presents as abnormal uterine bleeding, pain, and infertility.

Endometriosis

Endometriosis is the ectopic implantation and proliferation of endometrial glands and stromal tissue outside of the uterine endometrial lining.

The most common clinical presentation of endometriosis is a woman in her 20s or 30s that presents with infertility and the three D's:

Cyclic bleeding and symptoms correspond to hormonal status, and because these lesions are hormonally responsive the symptoms may worsen leading up to menstruation.

**Chocolate Cysts **(also known as an endometrioma) manifest when endometriosis is occurring in the ovaries, and with monthly hemorrhage it leads to the creation of a blood-containing cyst.

Chocolate cysts **vary with the menstrual cycle because they contain estrogen responsive endometrial tissue. **

The menstrual-type bleeding of the ectopic endometrium most commonly occurs in the ovary, and this forms blood-filled "chocolate cysts" and reddish-bluish-brown "powder-burn" serosal nodules Chocolate cysts of ovary. Caused by endometrium growing and shedding inside ovary. Powder burn serosal nodules

The first-line treatment for women with mild/moderate pain caused by endometriosis is NSAIDs plus combined(estrogen and progestin) oral contraceptives (OCPs). An alternative to combined OCPs is progestin-only hormonal therapy (e.g. medroxyprogesterone).

Danazol is a synthetic androgen that acts to inhibit FSH and LH production by the anterior pituitary (negative feedback). It is FDA-approved to treat women with endometriosis-related pain; however, it is rarely used due to its adverse effects (hirsutism, acne, hepatotoxicity, etc.)

Women with severe/refractory symptoms due to endometriosis can be treated with GnRH agonists such as leuprolide.

Women with endometriosis that fail medical therapy are candidates for laparoscopic excision of the endometriosis lesions.

Adenomyosis

Adenomyosis refers to the presence of endometrial glands and/or stroma within the uterine myometrium.

Adenomyosis will commonly present with menorrhagia, dysmenorrhea. Patients with adenomyosis will have a symmetrically enlarged “boggy” uterus found on bimanual exam. The diagnosis of adenomyosis is made with biopsy, and the definitive treatment is with hysterectomy.

A boggy uterus is a finding upon physical examination where the uterus is more flaccid than would be expected.

Endometrial hyperplasia

Endometrial hyperplasia is the abnormal proliferation of endometrial glands relative to stroma; usually caused by excess unopposed estrogen stimulation (obesity, PCOS, estrogen replacement)

The risk factors for endometrial hyperplasia are related to increased exposure of unopposed estrogen:

Endometrial hyperplasia usually presents as postmenopausal vaginal bleeding.

Classified histologically based on architectural growth pattern (simple or complex) and the presence or absence of cellular atypia. The most important predictor for progression to carcinoma is the presence of nuclear atypia.

Endometrial hyperplasia is a precursor to endometrial carcinoma, thus patients with endometrial hyperplasia are at **\ increased risk of developing endometrial carcinoma. **

Endometrial carcinoma

Endometrial carcinoma is a malignant proliferation of endometrial glands (adenocarcinoma).

Most common invasive carcinoma of the female genital tract.

Endometrial carcinoma most commonly presents in patients between ages 60 and 70, and classically presents with post-menopausal vaginal bleeding.

There are two distinct pathways that lead to the development of endometrial carcinoma:

The risk factors for endometrial carcinoma include:

The prognosis of endometrial carcinoma correlates with degree of myometrial invasion (the deeper it invades, the worse the prognosis).  Think of its progression as an uncontrolled proliferative (follicular) phase of menstrual cycle: Normal endometrium transforms into simple hyperplasia, which transforms into complex hyperplasia, then atypical hyperplasia, and finally results in endometrial adenocarcinoma.

Leiomyoma

(Fibroid) is a benign proliferation of myometrial smooth muscle cells

It often presents with multiple discrete tumors that are well-demarcated (i.e. encapsulated) by a pseudocapsule. No necrosis or hemorrhage Uterine cavity in middle:

Whorled patterns of smooth muscles on microscopic exam

Most common benign tumors in women.

The peak occurrence is seen in African American women between **20 and 40 years of age. ** (Premenopausal women because responsive to estrogen)

Abnormal uterine bleeding (e.g. menorrhagia, postcoital spotting), which is by far the most common symptom → chronic iron deficiency anemia (dizziness, weakness, fatigue) if the bleeding is severe. Due to impringe on pelvic structures. No pain

Fibroids are hormonally responsive to estrogen (and to progesterone), and as a result they may:

Leiomyomas do not progress to a leiomyosarcoma.

There is recent evidence that leiomyomas may also produce EPO (which can potentially cause erythrocytosis).

Treatment:

Leiomyosarcoma

Leiomyosarcoma is a malignant proliferation of smooth muscle arising from the myometrium that typically arises de novo (they do NOT arise from a leiomyoma).

Leiomyosarcomas have an increased incidence in African Americans. Often in postmenopausal women.

Leiomyosarcomas are a highly aggressive tumor with a tendency to recur. They commonly present as a bleeding mass fungating from the myometrium into the lumen of the uterus, sometimes even protruding through the cervix.

Grossly, leiomyosarcomas appear as bulky irregularly shaped tumors with areas of necrosis and hemorrhage. Histological features include necrosis, mitotic activity, and cellular atypia. (single lesion)

Asherman Syndrome

Repeated dilation and curettage (D&C) procedures that remove the stratum basalis, the stem cell layer of the endometrium that generates functionalis layer for growth and shedding. This renders the endometrium unable to regenerate, resulting in endometrial fibrosis and scarring. Asherman syndrome is an etiology of secondary amenorrhea.

Anovolatory Cycle

Anovulatory cycle is a condition characterized by a lack of ovulation. It results in an estrogen-driven proliferative phase without a subsequent progesterone-driven secretory phase. Proliferative glands eventually break down and shed resulting in uterine bleeding. It represents a common cause of dysfunctional uterine bleeding, especially during menarche and prior to menopause.

Endometrial polyp

Backlinks